Statistics
Publications
2
Citations
126
H-Index
2
Active since
1992
Affiliations
National Cancer Institute(Current)
Ingalill L. Avis is an author at National Cancer Institute specializing in oncology, medicine, and monoclonal antibodies in oncology.
Publications per year
1992–1997
2
2
The correct dose: pharmacologically guided end point for anti-growth factor therapy.
James L. Mulshine, Noriyuki Shuke, Farhad Daghighian et al. · PubMed · 1992 · 17 citations
Medicine, Oncology, Pharmacology +14
1–2 of 2